402 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Kelsen
    Kelsen
  4. Seidman
    Seidman
  5. Motzer
    Motzer
  6. Saltz
    Saltz
  7. Aghajanian
    Aghajanian
  8. Spriggs
    Spriggs
  9. Kemeny
    Kemeny
  10. Kris
    Kris

Groups

  1. Department of Medicine (247)
  2. Solid Tumor Oncology Division (212)
  3. Survivorship Research (83)
  4. Breast Medicine Service (70)
  5. Gastrointestinal Oncology Service (53)
  6. Genitourinary Oncology Service (50)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (49)
  8. Epidemiology and Biostatistics (49)
  9. Center for Pancreatic Cancer Research (44)
  10. Hematologic Malignancies, Division of (44)
  1. "drug administration schedule"
Formats
  1. Journal Article (392)
  2. Conference Paper (10)
Groups
  1. Department of Medicine (247)
  2. Solid Tumor Oncology Division (212)
  3. Survivorship Research (83)
  4. Breast Medicine Service (70)
  5. Gastrointestinal Oncology Service (53)
  6. Genitourinary Oncology Service (50)

More Groups

People
  1. Clifford Hudis (32)
  2. Larry Norton (30)
  3. Andrew Seidman (25)
  4. David Kelsen (25)
  5. Nancy Kemeny (24)
  6. Robert Motzer (24)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (1)
  5. 2019 (1)
  6. 2017 (7)

More Years

Publications
  1. Journal of Clinical Oncology (82)
  2. Cancer (34)
  3. Clinical Cancer Research (23)
  4. Seminars in Oncology (18)
  5. Gynecologic Oncology (16)
  6. JNCI: Journal of the National Cancer Institute (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (83)
  2. Elsevier Inc. (62)
  3. Wiley Blackwell (39)
  4. American Association for Cancer Research (36)
  5. Oxford University Press (27)
  6. Springer (26)

More Publishers

Results (402)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effect of tadalafil once daily on penile length loss and morning erections in patients after bilateral nerve-sparing radical prostatectomy: Results from a randomized controlled trial
    Journal Article

    Brock, G.; Montorsi, F.; Costa, P.; Shah, N.; Martinez-Jabaloyas, J. M.; Hammerer, P.; Ludovico, G. M.; Lee, J. C.; Henneges, C.; Hamidi, K.; more...
    Urology (2015)

    Fulltext@MSK | Save
  • Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Hudes, G. R.; Figlin, R. A.; Martini, J. F.; English, P. A.; Huang, X.; Valota, O.; Williams, J. A.
    Cancer Chemotherapy and Pharmacology (2014)

    Fulltext@MSK | Save
  • Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma
    Journal Article

    Milowsky, M. I.; Dittrich, C.; Durán, I.; Jagdev, S.; Millard, F. E.; Sweeney, C. J.; Bajorin, D.; Cerbone, L.; Quinn, D. I.; Stadler, W. M.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline
    Journal Article

    Giordano, S. H.; Temin, S.; Kirshner, J. J.; Chandarlapaty, S.; Crews, J. R.; Davidson, N. E.; Esteva, F. J.; Gonzalez-Angulo, A. M.; Krop, I.; Levinson, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: Pathologic, radiologic, and biomarker correlates
    Journal Article

    Choueiri, T. K.; Jacobus, S.; Bellmunt, J.; Qu, A.; Appleman, L. J.; Tretter, C.; Bubley, G. J.; Stack, E. C.; Signoretti, S.; Walsh, M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Anaphylaxis caused by repetitive doses of a GITR agonist monoclonal antibody in mice
    Journal Article

    Murphy, J. T.; Burey, A.; Beebe, A. M.; Gu, D.; Presta, L. G.; Merghoub, T.; Wolchok, J. D.
    Blood (2014)

    Fulltext@MSK | Save
  • Pharmacokinetics-based integration of multiple doses of intravenous pegaspargase in a pediatric regimen for adults with newly diagnosed acute lymphoblastic leukemia
    Journal Article

    Douer, D.; Aldoss, I.; Lunning, M. A.; Burke, P. W.; Ramezani, L.; Mark, L.; Vrona, J.; Park, J. H.; Tallman, M. S.; Avramis, V. I.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy: Analysis from the NeoALTTO trial
    Journal Article

    Azim, H. A. Jr; Agbor-Tarh, D.; Bradbury, I.; Dinh, P.; Baselga, J.; Di Cosimo, S.; Greger, J. G. Jr; Smith, I.; Jackisch, C.; Kim, S. B.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment
    Journal Article

    Hu, M. I.; Glezerman, I.; Leboulleux, S.; Insogna, K.; Gucalp, R.; Misiorowski, W.; Yu, B.; Ying, W.; Jain, R. K.
    JNCI: Journal of the National Cancer Institute (2013)

    Fulltext@MSK | Save
  • Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer
    Journal Article

    Baselga, J.; Gomez, P.; Greil, R.; Braga, S.; Climent, M. A.; Wardley, A. M.; Kaufman, B.; Stemmer, S. M.; Pêgo, A.; Chan, A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save